Searchable abstracts of presentations at key conferences in endocrinology

ea0029oc19.6 | Cardiovascular Endocrinology | ICEECE2012

Endothelial progenitor cells in acromegaly are reduced and responsive to treatment with somatostatin analogues

Albano I. , Fadini G. , Dassie F. , Martini C. , Agostini C. , Avogaro A. , Sicolo N. , Vettor R. , Maffei P.

Introduction: Acromegaly is characterized by high cardiovascular morbidity and mortality possibly due to increased prevalence of main traditional cardiovascular risk factors. It is not clear though whether the incidence of atherosclerosis is truly enhanced. Moreover recent in vitro studies show a protective role of (GH) and IGF1 (insulin-like growth factor-1) on the endothelium. As expression of endothelial regenerative reserve, endothelial progenitor cells (EPCs) could...